If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

Share Price is delayed by 15 minutes
Get Live Data
585.00    -3.00 (-0.51%)
Bid:
580.00
Ask:
590.00
Spread: 10.00 (1.724%)
Market Cap: £237.41m
SAG Live PriceLast checked at - London Stock Exchange

Intraday Science Group Share Chart

Trading Update

11 Nov 2024 07:00

RNS Number : 5909L
Science Group PLC
11 November 2024
 

 

11 November 2024

 

Science Group plc

(the "Company" or "Science Group")

 

Trading Update

 

 

The Group's trading performance for FY24 remains on track to deliver another record year of adjusted operating profit in line with expectations.

 

While not immune to the UK and international political/economic environment, Science Group benefits from the resilience inherent in its portfolio. In that regard, the UK budget on 30 October 2024 increased Employer's National Insurance with an estimated annualised increase to the Group's operating cost base in the order of £0.7 million. The Board will consider how to mitigate this impact during the forthcoming 2025 planning cycle.

 

Science Group retains a very strong balance sheet with significant cash resources. At 31 October 2024, the Group had gross cash of £37.7 million and net funds of £25.6 million, after returning a total of £7.4 million to shareholders in 2024 through the buyback programme and an increased dividend. As announced on 22 October 2024, the operation of the share buyback programme is now delegated to Panmure Liberum.

 

The Group's Term Loan expires in September 2026. In addition, the Group has an undrawn Revolving Credit Facility ("RCF") of £25 million which is available until December 2026. In order to support the Group's corporate strategy, the Board is considering:

 

· Refinancing the Term Loan for a new 10 year period, secured on the Group's freehold properties, and

· Renewing the RCF on a new 5 year term and increasing the facility to £30 million with an additional £10 million accordion option.

 

Negotiations are progressing well and term sheets have been agreed. Legal documentation is anticipated to take several weeks. If concluded on satisfactory terms, these new, increased facilities with extended commitment periods, combined with the Group's existing cash resources, would strengthen Science Group's ability to continue to consider corporate opportunities which may arise.

 

 

- Ends -

 

 

For further information:

Science Group plc

Martyn Ratcliffe, Executive Chair

Tel: +44 (0) 1223 875 200

Jon Brett, Finance Director

www.sciencegroup.com  

Cannacord Genuity Limited (Nominated Adviser and Joint Broker)

Simon Bridges, Andrew Potts

Tel: +44 (0) 20 7523 8000

Panmure Liberum Capital Limited (Joint Broker)

Max Jones, John More

Tel: +44 (0) 20 3100 2000

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUWANRSVUARAA
Date   Source Headline
1st Apr 20257:01 amRNSIncreased Shareholding in Ricardo plc
1st Apr 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
31st Mar 20255:35 pmRNSHolding(s) in Company
31st Mar 20257:01 amRNS-RUpdate on Ricardo plc
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20257:00 amRNSTreasury shares issued
27th Mar 20259:21 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSExecutive Chair Share Purchase
26th Mar 20257:00 amRNSExecutive Chair Share Purchase
25th Mar 20252:20 pmRNSDirector Dealing
24th Mar 20257:00 amRNSAudited Results for Year Ended 31 December 2024
20th Mar 20257:00 amRNSNotice of Preliminary Results
19th Mar 202512:33 pmRNSHolding(s) in Company
19th Mar 20257:01 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSBank Refinancing & Ricardo Strategic Investment
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:01 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSResponse to Ricardo plc
14th Mar 20253:15 pmRNSResponse to Science Group plc
14th Mar 202510:38 amRNSHolding(s) in Company
14th Mar 20257:01 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSIncreased Shareholding in Ricardo plc
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 202510:54 amRNSHolding(s) in Company
11th Mar 20258:29 amRNSShareholding in Ricardo plc
10th Mar 20252:19 pmRNSHolding(s) in Company
10th Mar 20251:42 pmRNSIncreased Shareholding in Ricardo plc
10th Mar 20257:00 amRNSTransaction in Own Shares
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20253:31 pmRNSHolding(s) in Company
3rd Mar 20253:30 pmRNSHolding(s) in Company
3rd Mar 202510:05 amRNSIncreased Shareholding in Ricardo plc
28th Feb 20257:01 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSStrategic Investment in Ricardo plc
27th Feb 20257:00 amRNSTransaction in Own Shares
21st Feb 20257:00 amRNSTransaction in Own Shares
14th Feb 20257:00 amRNSTransaction in Own Shares
12th Feb 20257:00 amRNSTransaction in Own Shares
11th Feb 20257:00 amRNSTransaction in Own Shares
7th Feb 20257:00 amRNSTransaction in Own Shares
5th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTransaction in Own Shares
15th Jan 20257:00 amRNSTransaction in Own Shares
14th Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20257:01 amRNSTransaction in Own Shares
13th Jan 20257:00 amRNSFY24 Trading Update & 2025 Buy-Back Programme
2nd Jan 20257:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.